Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 501–600 of 1,012
Egner, R., Mahé, Y., Pandjaitan, R., & Kuchler, K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.5879 · Cited by 127
“For instance, transcription factors such as Pdr1 (2), Yap1/Snq3 (22, 37), Pdr3 (14, 26), and, putatively, Pdr7 and Pdr9 (15) may form a highly complicated network implicated in MDR development (3), similar to P-glycoprotein- or MRP-mediated MDR in mammalian cells.”
BackgroundKralli, A., & Yamamoto, K. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17152 · Cited by 125
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
Anreddy, N., Gupta, P., Kathawala, R. J., Patel, A. S., Wurpel, J. N. D., & Chen, Z. (2014) · Molecules · doi:10.3390/molecules190913848 · Cited by 131
“ABCB1/P-glycoprotein (P-gp/MDR1) ABCB1 has a molecular weight of 160-170-kDa and consists of two TMDs and two NBDs [28,52].”
BackgroundInfluentialZhu, X., Li, H., Long, L., Hui, L., Chen, H., Wang, X., Shen, H., & Xu, W. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms026 · Cited by 130
Volk, E. L., Rohde, K., Rhee, M., McGuire, J. J., Doyle, L. A., Ross, D. D., & Schneider, E. (2000) · PubMed · Cited by 125
Frangne, N., Eggmann, T., Koblischke, C., Weissenböck, G., Martinoia, E., & Klein, M. (2002) · PLANT PHYSIOLOGY · doi:10.1104/pp.010590 · Cited by 124
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.11 · Cited by 140
Self-citationABC transporters and their role in nucleoside and nucleotide drug resistance
Fukuda, Y., & Schuetz, J. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.042 · Cited by 121
“The first was identified by the laboratories of Cole and Deeley in 1991 and is referred to as multidrug resistance protein 1 (MRP1/ABCC1) [20].”
BackgroundP‐glycoprotein: So Many Ways to Turn It On
Callaghan, R., Crowley, E., Biochem, M., Potter, S., & Kerr, I. D. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007311568 · Cited by 123
Crowe, A. P., & Lemaire, M. (1998) · Pharmaceutical Research · doi:10.1023/a:1011940108365 · Cited by 123
Oda, Y., Ohishi, Y., Saito, T., Hinoshita, E., Uchiumi, T., Kinukawa, N., Iwamoto, Y., Kohno, K., Kuwano, M., & Tsuneyoshi, M. (2003) · The Journal of Pathology · doi:10.1002/path.1282 · Cited by 123
“Multidrug resistance-associated protein (MRP) 1 is a 190 kD ABC superfamily transporter that shares 15% amino acid homology with P-gp [8].”
BackgroundStrategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Borowski, E., Bontemps‐Gracz, M. M., & Piwkowska, A. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3421 · Cited by 128
“Because of the specific character of this type of resistance, it was usually possible to circumvent it by switching from one antitumor drug to another or by appropriate chemical modification of the antitumor agent.”
BackgroundABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome
Elliott, A. M., & Al‐Hajj, M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0235 · Cited by 127
“cells selected for doxorubicin resistance (4, 17, 20-22).”
BackgroundDrug transporters, the blood-testis barrier and spermatogenesis
Su, L., Mruk, D. D., & Cheng, C. Y. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0363 · Cited by 146
Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
Lockhart, A. C., Tirona, R. G., & Kim, R. B. (2003) · PubMed · Cited by 141
The pharmacology of cancer resistance.
O'Connor, R. A. (2007) · PubMed · Cited by 123
Nies, A. T., Schwab, M. G., & KEPPLER, D. O. R. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.545 · Cited by 131
“MRP1 (ABCC1) was the first ABCC/MRP transporter to be cloned [49] .”
BackgroundOvercoming Chemotherapy Resistance in SCLC
Herzog, B. H., Devarakonda, S. H. K., & Govindan, R. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.07.018 · Cited by 132
Datta, R., Manome, Y., Taneja, N., Boise, L., Weichselbaum, R. R., Thompson, C. B., Slapak, C. A., & Kufe, D. W. (1995) · PubMed · Cited by 129
Investigational ABC transporter inhibitors
Falasca, M., & Linton, K. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.679339 · Cited by 120
“2 ABCC subfamily transporters ABCC1, cloned in 1992, encodes a 190-kDa protein that is highly expressed in the kidney, lung, striated muscle, placenta and testis [25].”
BackgroundAlsharif, N. H., Berger, C. E. M., Varanasi, S. S., Chao, Y., Horrocks, B. R., & Datta, H. K. (2008) · Small · doi:10.1002/smll.200800903 · Cited by 131
Evidence for Different ABC-Transporters in Caco-2 Cells Modulating Drug Uptake
Gutmann, H., Fricker, G., Török, M., Michael, S., Beglinger, C., & Drewe, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018825819249 · Cited by 121
KEPPLER, D. O. R., Leier, I., Jedlitschky, G., & König, J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00158-0 · Cited by 140
Taguchi, Y., Yoshida, A., Takada, Y., Komano, T., & Ueda, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01421-4 · Cited by 123
Uozaki, H., Horiuchi, H., Ishida, T., Iijima, T., Imamura, T., & Machinami, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2336::aid-cncr7>3.0.co;2-j · Cited by 121
ABC Transporters in the CNS – An Inventory
M.S. Hartz, A., & Bauer, B. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164020 · Cited by 120
miR-134: A Human Cancer Suppressor?
Pan, J., Zhang, F., Sun, C., Li, S., Li, G., Gong, F., Bo, T., He, J., Hua, R., Hu, W., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.11.003 · Cited by 129
ABC Transporters and Drug Efflux at the Blood-Brain Barrier
Shen, S., & Zhang, W. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.1.29 · Cited by 132
Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to oxyanion resistance.
Papadopoulou, B., Roy, G., Dey, S., Rosen, B. P., & Ouellette, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32670-4 · Cited by 120
Luker, G. D., Fracasso, P. M., Dobkin, J. B., & Piwnica-Worms, D. (1997) · PubMed · Cited by 120
Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene.
Kruh, G. D., Chan, A. M.-L., Myers, K., Gaughan, K., Miki, T., & Aaronson, S. A. (1994) · PubMed · Cited by 120
How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?
Jaramillo, A. C., Saig, F. A., Cloos, J. J., Jansen, G., & Peters, G. J. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.02 · Cited by 124
“MULTI-DRUG ASSOCIATED PROTEIN 1 A decade after the discovery of P-gp, the first member of the C subfamily, MRP1 (systematic name, ABCC1) was discovered([41]).”
Sandusky, G. E., Mintze, K., Pratt, S. E., & Dantzig, A. H. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01403.x · Cited by 141
Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer
Atkinson, D. E., Greenwood, S. L., Sibley, C. P., Glazier, J. D., & Fairbairn, L. J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00418.2002 · Cited by 118
“CAGCCACAGGAGGTAGAGAG-3’, bases 1557-1576) of the human MRP1 gene ( 4 ).”
BackgroundMahé, Y., Parle‐McDermott, A., Nourani, A., Delahodde, A., Lamprecht, A., & Kuchler, K. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02493.x · Cited by 117
Recent Advances in the Medicinal Chemistry of Aurones
Haudecoeur, R., & Boumendjel, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800672085 · Cited by 129
Shain, K. H., & Dalton, W. S. (2001) · PubMed · Cited by 140
Mechanisms of Multidrug Resistance
Kellen, J. A. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9852-7_1 · Cited by 117
Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes
Inokuchi, A., Hinoshita, E., Iwamoto, Y., Kohno, K., Kuwano, M., & Uchiumi, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104612200 · Cited by 130
RENES, J., DE VRIES, E. E. G., HOOIVELD, G. J. E. J., KRIKKEN, I., JANSEN, P. L. M., & MÜLLER, M. (2000) · Biochemical Journal · doi:10.1042/bj3500555 · Cited by 116
Renal Tubular Drug Transporters
Launay-Vacher, V., Izzedine, H., Karie, S., Hulot, J. S., Baumelou, A., & Deray, G. (2006) · Nephron Physiology · doi:10.1159/000092212 · Cited by 116
“MRP1 (ABCC1) was the first identified from a multiresistant Eisai hyperbilirubinemic-resistant (EHBR) lung cancer. Mice homozygote for the gene coding for MRP1 exhibited high susceptibility to drugs [”
BackgroundMichieli, M., Damiani, D., Ermacora, A., Masolini, P., Raspadori, D., Visani, G., Scheper, R. J., & Baccarani, M. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01172.x · Cited by 116
“…cells, because, as previously discussed (Michieli et al, 1997), all three genes (mdr-1, lrp and mrp) are present in normal cells and their products can be physiologically expressed also in haemopoietic cells and in other tissues (Pileri et al, 1991; Cole et al, 1992; Izquierdo et al, 1996a).”
BackgroundPharmacologic circumvention of multidrug resistance
Ford, J. M., & Hait, W. N. (1993) · Cytotechnology · doi:10.1007/bf00744664 · Cited by 127
“…et al., 1991b; Bear et al., 1992), proteins involved in peptide transport and presentation in MHC-restricted immune cells (Spies et al., 1990; Trowsdale et al., 1990), and additional related proteins potentially involved in mammalian drug resistance (Cole et al., 1992; Scheper et al., 1993).”
BackgroundRumjanek, V. M., Trindade, G. S., Wagner-Souza, K., MELETTI-DE-OLIVEIRA, M. C., Marques‐Santos, L. F., Maia, R. C., & Capella, M. A. M. (2001) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652001000100007 · Cited by 129
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
Hjarnaa, P. V., Jonsson, E. W., Latini, S., Dhar, S., Larsson, R., Bramm, E., Skov, T., & Binderup, L. (1999) · PubMed · Cited by 115
Couture, L., Nash, J. A., & Turgeon, J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.7 · Cited by 147
Morjani, H., Aouali, N., Belhoussine, R., Veldman, R. J., Levade, T., & Manfait, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1449 · Cited by 126
Aye, I. L. M. H., Singh, A. T., & Keelan, J. A. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.04.012 · Cited by 134
“[21] S.”
Backgroundvan Zanden, J. J., Geraets, L., Wortelboer, H. M., van BLADEREN, P. J., Rietjens, I. M. C. M., & Cnubben, N. H. P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.032 · Cited by 123
Štaud, F., Červený, L., & Čečková, M. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.716847 · Cited by 126
“The first transporter of the MRP family, MRP1, was cloned two decades ago by Cole and colleagues (Cole et al., 1992) and shortly afterwards described as an ATP-dependent efflux transporter for anionic conjugates (Jedlitschky et al.”
BackgroundEneroth, A., Åström, E., Hoogstraate, J. A., Schrenk, D., Conrad, S., Kauffmann, H.-M., & Gjellan, K. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00117-2 · Cited by 113
Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells
Cho, S., Lu, M., He, X., Ee, P.-L. R., Bhat, U., Schneider, E., Miele, L., & Beck, W. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019452108 · Cited by 113
“Explication of MDR in cancers has revealed many mechanisms (3–7), including overexpression of ATP-binding cassette (ABC) membrane transporters such as P-glycoprotein (ABCB1/MDR1; Pgp) (8, 9), MDR protein 1 (ABCC1/MRP1; herein referred to as ABCC1) (10), and breast cancer resistance protein (ABCG2/BCRP) (11).”
BackgroundKornmann, M., Danenberg, K. D., Arber, N., Beger, H. G., Danenberg, P. V., & Korc, M. (1999) · PubMed · Cited by 125
Tumor Cell Responses to a Novel Glutathione S-Transferase–Activated Nitric Oxide-Releasing Prodrug
Findlay, V. J., Townsend, D. M., Saavedra, J. E., Buzard, G. S., Citro, M. L., Keefer, L. K., Ji, X., & Tew, K. D. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1070 · Cited by 114
“The efflux of GS-conjugates from the cell is achieved by multidrug resistance-associated protein (MRP1), a member of the ATP-binding cassette transporter superfamily (Cole et al., 1992).”
BackgroundDNA damage repair and tolerance: a role in chemotherapeutic drug resistance
Salehan, M. R., & Morse, H. (2013) · British Journal of Biomedical Science · doi:10.1080/09674845.2013.11669927 · Cited by 128
The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle
Bryan, J., & Aguilar‐Bryan, L. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80033-6 · Cited by 114
Piwnica-Worms, D., Rao, V. V., Kronauge, J. F., & Croop, J. M. (1995) · Biochemistry · doi:10.1021/bi00038a015 · Cited by 121
A Perspective on Efflux Transport Proteins in the Liver
Köck, K., & Brouwer, K. L. R. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.79 · Cited by 112
Mechanisms of pruritus in cholestasis: understanding and treating the itch
Beuers, U. H., Wolters, F., & Elferink, R. P. J. O. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00687-7 · Cited by 132
Clinical studies of reversal of drug resistance based on glutathione
Calvert, P. M., Yao, K.-S., Hamilton, T. C., & O'Dwyer, P. J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00008-8 · Cited by 112
Mantovani, G., Macciò, A., Pisano, M., Versace, R., Lai, P., Esu, S., Massa, E., Ghiani, M., Dessì, D., Melis, G. B., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<817::aid-ijc20>3.0.co;2-3 · Cited by 45
Mor-Cohen, R., Zivelin, A., Rosenberg, N., Shani, M., Muallem, S., & Seligsohn, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105047200 · Cited by 112
Zhou, B., Sun, C., Li, N., Shan, W., Lü, H., Guo, L., Guo, E., Xia, M., WENG, D., Li, M., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3442 · Cited by 114
Liao, W., Lü, C., Hartmann, R., Wang, F., Sohn, Y. S., Parak, W. J., & Willner, I. (2015) · ACS Nano · doi:10.1021/acsnano.5b03223 · Cited by 112
Seebacher, N. A., Richardson, D. R., & Jansson, P. J. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.381 · Cited by 111
“A major limitation of the cytotoxic chemotherapeutic, Doxorubicin (DOX; Figure 1ai), is resistance caused by drug-resistance pumps, for example, P-glycoprotein (Pgp).(1,2) This has been attributed to both Pgp-mediated drug efflux through the plasma membrane(3) and also due to increased Pgp-mediated drug trapping withi…”
BackgroundGlycosphingolipids and drug resistance.
Gouazé-Andersson, V., & Cabot, M. (2006) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2006.08.012 · Cited by 115
Pharmacophore-based discovery of ligands for drug transporters
Chang, C. K., Ekins, S., Bahadduri, P. M., & Swaan, P. W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.006 · Cited by 124
“3.4 MRP1 The multidrug resistance protein 1 (MRP1) is another efflux transporter that contributes to MDR [99].”
BackgroundInfluentialLipid Traffic: The ABC of Transbilayer Movement
Raggers, R. J., Pomorski, T., Holthuis, J. C. M., Kälin, N., & van Meer, G. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010305.x · Cited by 111
“MDR3 P-gp displays 80% homology with MDR1 P-gp, a multidrug transporter, and it has been suggested that MDR3 P-gp also pumps certain drugs (38).”
BackgroundInfluentialFunctional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver
Ito, K., Suzuki, H., Hirohashi, T., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1684 · Cited by 117
Sugawara, I., Akiyama, S., Scheper, R. J., & Itoyama, S. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04542-9 · Cited by 122
Paulusma, C. C., & Elferink, R. P. J. O. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050127 · Cited by 123
“The hMRP1 cDNA encodes a 1531 amino acid [57] member of the ABC transporter family which confers resistance to many structurally and functionally unrelated substrates (reviewed in [60]).”
BackgroundInfluentialKruijtzer, C. M. F., Beijnen, J. H., & Schellens, J. H. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-516 · Cited by 110
Kast, C., & Gros, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26479 · Cited by 123
Tafuri, A. (2002) · Blood · doi:10.1182/blood-2001-12-0371 · Cited by 110
“MRP1 is a protein distinct from MDR1 because of its substrate specificity (amphophilic anions or glutathioneconjugated) and for the type of drugs that can restore chemotherapy sensitivity (butathionine, which depletes intracellular glutathione content) (14,15).”
BackgroundSugimoto, Y., Tsukahara, S., Imai, Y., Sugimoto, Y., Ueda, K., & Tsuruo, T. (2003) · PubMed · Cited by 115
Jones, K., Hoggard, P. G., Sales, S. D., Khoo, S., Davey, R., & Back, D. J. (2001) · AIDS · doi:10.1097/00002030-200104130-00002 · Cited by 110
“MRP1 is a 190 kDa transmembrane ef ̄ux pump that has been shown to be present on a number of drugresistant cancers that have little or no expression of Pgp [10].”
BackgroundNew Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
An, J., Peng, C. Y., Tang, H., Liu, X., & Peng, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179644 · Cited by 125
“When neoadjuvant chemotherapy drugs are used for a long time, the genes encoding the above-mentioned proteins are overexpressed, which increases drug efflux and causes resistance to neoadjuvant chemotherapy [24,25].”
BackgroundDingemans, A. C., Witlox, A. M. A., Stallaert, R. A. L. M., van der Valk, P., Postmus, P. E., & Giaccone, G. (1999) · PubMed · Cited by 109
Tada, Y., Wada, M., Migita, T., Nagayama, J., Hinoshita, E., Mochida, Y., Maehara, Y., Tsuneyoshi, M., Kuwano, M., & Naito, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10246 · Cited by 108
Pharmacogenomics of MRP Transporters (ABCC1-5) and BCRP (ABCG2)
Gradhand, U., & Kim, R. B. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952617 · Cited by 121
“MRP1 was initially identified in a human lung cancer cell line (Cole et al., 1992), but has now been detected in many human cell types (Flens et al.”
BackgroundGollapudi, S., Kim, C. H., Tran, B.-N., Sangha, S., & Gupta, S. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050640 · Cited by 109
“Both P-gP and MRP are members of the ATP-binding cassette superfamily of membrane transport proteins [4, 5].”
BackgroundMultidrug-Resistance Transporters
Silverman, J. A. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-46812-3_13 · Cited by 123
Novel Extracellular Vesicles Mediate an ABCG2-Dependent Anticancer Drug Sequestration and Resistance
Ifergan, I., Scheffer, G. L., & Assaraf, Y. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2021 · Cited by 107
Lang, T., Hitzl, M., Burk, O., Mornhinweg, E., Keil, A., Kerb, R., Klein, K., Zanger, U. M., Eichelbaum, M. F., & Fromm, M. F. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00003 · Cited by 116
Suzuki, H., Koyanagi, T., Izuka, S., Onishi, A., & Kumagai, H. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.17.5861-5867.2005 · Cited by 108
“The glutathione importers Na -dependent transporter (10) and H symporter (9) are known, and the only glutathione transporters with the ATPbinding cassette identified so far are glutathione S conjugate exporters (4).”
BackgroundSignificance of ABC transporters in fungicide sensitivity and resistance
Waard, M. A. D. (1997) · Pesticide Science · doi:10.1002/(sici)1096-9063(199711)51:3<271::aid-ps642>3.0.co;2-# · Cited by 132
Kuete, V., Tchakam, P. D., Wiench, B., Ngameni, B., Wabo, H. K., Tala, M. F., Moungang, L. M., Ngadjui, B. T., Murayama, T., & Efferth, T. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.02.003 · Cited by 109
“MRP1 confers resistance to antracyclines, Vinca alkaloids, taxanes, epipodophyllotoxins, platinum compounds and methotrexate (Cole et al. 1992; Deeley et al. 2006).”
BackgroundGreen, S. K., Francia, G., Isidoro, C., & Kerbel, R. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.149.3.2 · Cited by 107
“Multicellular resistance (2, 3) differs from many other resistance mechanisms that are unicellular in nature, such as that conferred by overexpression of P-glycoprotein (31) or the multidrug resistance-associated protein (32), in that it is uniquely manifested in vitro when cancer cells are grown as three-dimensional…”
BackgroundBiological Profile of Erucin: A New Promising Anticancer Agent from Cruciferous Vegetables
Melchini, A., & Τράκα, Μ. (2010) · Toxins · doi:10.3390/toxins2040593 · Cited by 123
Kuwano, M., Uchiumi, T., Hayakawa, H., Ono, M., Wada, M., Izumi, H., & Kohno, K. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01344.x · Cited by 106
Conrad, S., Kauffmann, H.-M., Ito, K., Leslie, E. M., Deeley, R. G., Schrenk, D., & Cole, S. P. C. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00008 · Cited by 119
Self-citationIdentification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12
Scolari, F., Puzzer, D., Amoroso, A., Caridi, G., Ghiggeri, G. M., Maiorca, R., Aridon, P., Fusco, M. D., Ballabio, A., & Casari, G. (1999) · The American Journal of Human Genetics · doi:10.1086/302414 · Cited by 107
“…some known genes, map to this critical region, including a phosphodiesterase gene (Bolger et al. 1993), the multidrug resistance-associated protein (Cole et al. 1992), the alanine aminotransferase (Sohocki et al. 1997), the ubiquinol-cytochrome c reductase complex core protein 2 precursor…”
BackgroundKoukouritaki, S. B., Margioris, A. N., Gravanis, A., Hartig, R., & Stournaras, C. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970615)65:4<492::aid-jcb5>3.0.co;2-j · Cited by 55
Duesberg, P., Stindl, R., & Hehlmann, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201398998 · Cited by 106
Efflux transport systems for organic anions and cations at the blood?CSF barrier
Kusuhara, H., & Sugiyama, Y. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.007 · Cited by 117
Versantvoort, C., Broxterman, H., Lankelma, J., Feller, N., & Pinedo, H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90149-x · Cited by 110
Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites
Vyas, T. K., Shah, L. K., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.5.613 · Cited by 108
“These multi-drug transporters belong to the members of the ATP-binding cassette (ABC) family of transport proteins [62,63].”
BackgroundChearwae, W., Wu, C., Chu, H., Lee, T. R., Ambudkar, S. V., & Limtrakul, P. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0052-1 · Cited by 114
“The first of ABC transporter to be identified and characterized was the 170 kDa P-glycoprotein (P-gp) [1, 2] and then Multidrug Resistance Protein 1 (MRP1) was discovered in 1992 [10].”
Background[45] Transport function and substrate specificity of multidrug resistance protein
KEPPLER, D. O. R., Jedlitschky, G., & Leier, I. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)92047-x · Cited by 106
ABC Transporters and the Alzheimer’s Disease Enigma
Wolf, A., Bauer, B., & Hartz, A. M. S. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00054 · Cited by 103
“MRP1 was discovered by Cole et al. (1992) in the H69AR cancer cell line.”
Background
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.